The prognosis of acute kidney injury (AKI) in ICU patients might be indicated by levels of a complement factor B fragment.

Commit Biologics ("Commit"), a pioneer in the activation of the complement system to treat cancer and autoimmune disease, today announces ...

These PK/PD data support the selection of 8mg/kg as the optimal dose for intravenous administration every 8 weeks to achieve complete suppression (> 98 percent) of alternative pathway activation ...